Tag Archives: osu college of medicine

Meet Ohio State’s Personalized Health Care National Conference Speakers

The Ohio State University’s Center for Personalized Health Care is gathering academic leaders, industry experts, government policymakers and healthcare providers from across the country to discuss the latest developments in P4 Medicine, which is a novel approach to individualized medical care that engages consumer participationpredicts and prevents disease, facilitates health, and creates a personalized life strategy wellness plan for each individual.

The Johanna and Ralph DeStefano Personalized Health Care National Conference will be held Oct. 6-7 at the Blackwell Inn, located at 2110 Tuttle Park Place, on the campus of The Ohio State University.

With a theme of “The Future of P4 Medicine and Its Impact on Clinical Care,” attendees will hear from experts about revolutionizing medicine and transforming healthcare delivery in a way which will result in more precise, cost-effective and higher quality health care for patients. Topics will focus on the infrastructure necessary to enable P4 Medicine, applications of genetics and genomics in clinical medicine, the latest breakthroughs in science, patient engagement and the barriers to making P4 Medicine a reality.

Dr. Clay Marsh, executive director of OSU’s Center for Personalized Health Care,  shares: We are leading the way in bringing P4 Medicine to our patients and consumers, and this year’s conference is focusing on its future and its impact on clinical care. Having visionaries and leaders like Johanna DeStefano support our national conference is a critical factor to bringing P4 Medicine to the community, to reduce costs and improve outcomes of healthcare delivery.

This year’s keynote speakers include:

Leading as the conference’s first keynote speaker and discussing targeted cancer therapies, Dr. William Dalton is a cancer researcher who is interested in basic and translational research in molecular mechanisms of drug resistance and new drug discovery.

 

Dr. Carlo Croce, a physician-scientist world-renowned for his contributions involving the genes and genetic mechanisms implicated in the pathogenesis of human cancer.

 

Dr. Ralph Snyderman who developed Prospective Care, a novel approach to strategic health planning rather than reactive treatment of chronic disease, will discuss preventive medicine and healthcare reform.

 

The final keynote address of the conference will be given by Ann Pendleton-Jullian, who will discuss complex and adaptive systems in health care and making the connections to patient engagement.

 

Other speakers and expert panelists will discuss:

  • Novel approaches in the prediction and treatment of cancer
  • Advances in the prevention and treatment of cardiovascular disease
  • Community wellness
  • Creating a consumer-focused environment for participatory health care
  • Ohio as a center for healthcare reform, from a CEO’s perspective
  • P4 Medicine as a framework for value innovation (reducing cost and improving outcomes)

For more information about the conference program, registration, participating speakers and P4 Medicine, go to: http://cphc.osu.edu.

Personalized Medicine: A Shift from Reactive to Proactive Medicine

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

Leroy Hood, inventor of the first automated DNA sequencing machine and founder of the Institute for Systems Biology, recently granted an interview with MIT’s Technology Review to discuss his future plans for the company. Hood plans to help shape medicine to be more predictive, preventative and personal–and how The Ohio State University will play a role. When asked about his thoughts on the future of personalized medicine, Hood responded:

“I think personalized medicine is too narrow a view of what’s coming. I think we’ll see a shift from reactive medicine to proactive medicine. I define it as ‘P4′ medicine–powerfully predictive, personalized, preventative–meaning we’ll shift the focus to wellness–and participatory. That means persuading the various constituencies that this medicine is real and it’s here. Physicians will have to learn a medicine they didn’t learn in medical school.”

Hood continued on, highlighting the challenges ahead: “I think the biggest challenges will be societal acceptance of the revolution. We are putting together something we call the P4 Medical Institute. The idea is to bring in industrial partners as part of this consortium to help us transfer P4 medicine to the patient population at Ohio State University, which is both the payer and provider for its employees. We plan to announce further details of this project in two or three months.”

To read the full article and interview, please visit: http://www.technologyreview.com/biomedicine/24703/.

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

Ohio State Celebrates Research Day

main_photo_topIn observance of Research Day initiated by ResearchMeansHope.org and the Association of American Medical Colleges, The Ohio State University is hosting a reception today from 4-6 p.m. at Ohio State’s Biomedical Research Tower, Room 115. This event will present the opportunity to enjoy refreshments, network with your colleagues and share your story with us. Take a moment while you are at the reception to tell us on camera what research means to you.

Those in attendance will hear remarks of appreciation from the following: Eric Fingerhut, JD, Chancellor of the Ohio Board of Regents; Caroline Whitacre, PhD, Ohio State’s Vice President of Research; Steven Gabbe, MD, Senior Vice President for Health Sciences and CEO of OSU Medical Center; Wiley W. “Chip” Souba, MD, ScD, dean of Ohio State’s College of Medicine; Clay Marsh, MD, vice dean of Research for the OSU College of Medicine, and Rebecca Jackson, MD, director of Ohio State’s Center for Clinical and Translational Science.

ResearchMeansHope.org is a coalition of concerned patients and the physicians and researchers of America’s medical schools, teaching hospitals, universities, research companies and organizations. Their goal is to ensure sustained, real growth in federal support for medical research funded by the National Institutes of Health. Only through significant, annual increases in medical research funding can the promise of medical research be fulfilled.